Recent News

Share
520 News Items found
Pictured: Craig Thompson
Student Lecture Highlights Major Trends in Modern Cancer Research
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
Study Elucidates How Antibiotics Can Increase Some Harmful Infections in Cancer Patients
An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Sloan Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored
Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.
Participants in Cycle for Survival
Treating Rare Cancers
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Jedd Wolchok
Novel Immunotherapy Drug Receives FDA Approval for the Treatment of Metastatic Melanoma
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.
Pictured: Dimiter Tassev
First Gerstner Sloan Kettering Student Receives PhD Degree
Dimiter Tassev, a member of Gerstner Sloan Kettering's inaugural class, has completed all his degree requirements and will receive his PhD in May.
Memorial Sloan Kettering President Craig Thompson Welcomes Prospective Gerstner Sloan Kettering Students
Memorial Sloan Kettering Cancer Center and Gerstner Sloan Kettering President Craig Thompson and his wife opened their home for a reception for prospective Gerstner Sloan Kettering students invited for admissions interviews.
Bottles filled with liquid
Growing Science: A Decade Devoted to Advancing Cancer Research at the Sloan Kettering Institute
A decade ago, the Sloan Kettering Institute embarked on an effort to broaden and streamline its research activities.
Alexander Rudensky
Harmful Immune Reactions Might One Day Be Curbed with Cell-Based Therapy
A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.
Memorial Sloan Kettering Researchers Are 2010 Rock Stars of Science
Three Memorial Sloan Kettering Cancer Center investigators -- including the Center's new President, Craig B. Thompson -- have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in <i>GQ</i> magazine's December "Men of the Year" issue.